Basic Pharmacology For Nurses,15th Edition by Bruce D. Clayton
Basic Pharmacology For Nurses,15th Edition by Bruce D. Clayton
$2.99
Chapter 13: Drugs Affecting the Autonomic Nervous System
Complete Chapter Questions With Answers
Sample Questions Are Posted Below
MULTIPLE CHOICE
| A. | Hypertension |
| B. | Raynaud’s phenomenon |
| C. | Emphysema |
| D. | Cardiac dysrhythmias |
ANS: C
| Feedback | |
| A | Selective beta-1 antagonists are used to treat hypertension. |
| B | Alpha-adrenergic blocking agents are used to treat patients with Raynaud’s disease. |
| C | Beta-adrenergic blockers can produce severe bronchoconstriction. |
| D | Beta-adrenergic blocking agents are indicated for patients with cardiac arrhythmias. |
DIF: Cognitive Level: Application REF: 204
TOP: Nursing Process Step: Assessment
MSC: NCLEX Client Needs Category: Physiological Integrity
| A. | “The symptoms are usual and indicate that the medication is at a therapeutic level.” |
| B. | “The symptoms will tend to resolve with continued therapy.” |
| C. | “The symptoms are unusual and need to be reported to the health care provider immediately.” |
| D. | “The symptoms are indicative of toxicity.” |
ANS: B
| Feedback | |
| A | The therapeutic level can only be determined by analyzing a blood sample. |
| B | Terbutaline, an adrenergic agent effective for bronchodilation, can cause excessive CNS stimulation. Adverse effects such as palpitations, tachycardia, flushed skin, dizziness, and tremors tend to be mild and resolve with continued therapy. |
| C | These are common symptoms and should only be reported if they persist. |
| D | Symptoms of toxicity are chest pain, persistent palpitations, and tachycardia. |
DIF: Cognitive Level: Application REF: 202
TOP: Nursing Process Step: Evaluation
MSC: NCLEX Client Needs Category: Physiological Integrity
| A. | Bronchodilation |
| B. | Tachycardia |
| C. | Vasoconstriction |
| D. | Uterine relaxation |
ANS: C
| Feedback | |
| A | Alpha-1 receptor stimulation causes bronchoconstriction. |
| B | Alpha-1 receptor stimulation does not cause tachycardia. |
| C | Stimulation of the alpha-1 receptors causes vasoconstriction of all blood vessels throughout the body. |
| D | Beta-2 receptor stimulation produces relaxation of smooth muscle tissue, such as the uterus. |
DIF: Cognitive Level: Knowledge REF: 200
TOP: Nursing Process Step: Evaluation
MSC: NCLEX Client Needs Category: Physiological Integrity
| A. | Adrenergic agents |
| B. | Alpha-adrenergic blocking agents |
| C. | Beta-adrenergic blocking agents |
| D. | Cholinergic agents |
ANS: B
| Feedback | |
| A | Adrenergic drugs cause vasoconstriction. |
| B | Alpha-adrenergic–blocking agents interfere with the stimulation of alpha-1 and alpha-2 receptors. Because the primary action of alpha-receptor stimulation is vasoconstriction, alpha-adrenergic blocking agents are indicated for patients with diseases associated with vasoconstriction. |
| C | Beta-adrenergic blocking agents are used to treat hypertension and dysrhythmias. |
| D | Cholinergic drugs are used to treat ocular diseases such as glaucoma, respiratory tract disease, and urinary system diseases. |
DIF: Cognitive Level: Comprehension REF: 204
TOP: Nursing Process Step: Implementation
MSC: NCLEX Client Needs Category: Physiological Integrity
Original price was: $30.00.$20.00Current price is: $20.00.
Original price was: $100.00.$70.00Current price is: $70.00.
Original price was: $30.00.$20.00Current price is: $20.00.
Original price was: $35.00.$25.00Current price is: $25.00.
Original price was: $80.00.$60.00Current price is: $60.00.
